Soleno Therapeutics Inc (SLNO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -16,831 | -8,356 | -24,067 | -18,581 | -12,449 |
| Depreciation Amortization | 979 | 490 | 1,964 | 1,476 | 984 |
| Accounts payable and accrued liabilities | 1,679 | 1,001 | -1,477 | -930 | -848 |
| Other Working Capital | 925 | 114 | -756 | -503 | -602 |
| Other Operating Activity | 954 | 23 | 3,555 | 2,900 | 1,933 |
| Operating Cash Flow | $-12,294 | $-6,728 | $-20,781 | $-15,638 | $-10,982 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | -13 | -7 | -7 |
| Investing Cash Flow | $N/A | $N/A | $-13 | $-7 | $-7 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 17,060 | N/A | 14,108 | 14,108 | 13,766 |
| Other Financing Activity | 0 | 0 | -16 | -16 | -16 |
| Financing Cash Flow | $17,060 | $N/A | $14,092 | $14,092 | $13,750 |
| Beginning Cash Position | 14,602 | 14,602 | 21,304 | 21,304 | 21,304 |
| End Cash Position | 19,368 | 7,874 | 14,602 | 19,751 | 24,065 |
| Net Cash Flow | $4,766 | $-6,728 | $-6,702 | $-1,553 | $2,761 |
| Free Cash Flow | |||||
| Operating Cash Flow | -12,294 | -6,728 | -20,781 | -15,638 | -10,982 |
| Capital Expenditure | N/A | N/A | -13 | -7 | -7 |
| Free Cash Flow | -12,294 | -6,728 | -20,794 | -15,645 | -10,989 |